Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Gastroparesis Global Clinical Trials Review, H1, 2015

Published: Jan-2015 | Format: PDF | GlobalData | Number of pages: 88 | Code: MRS - 6293


GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H1, 2015"" provides data on the Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroparesis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastroparesis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Scope

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

 

Reasons to buy

 

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Content

 

Table of Contents 2
List of Tables 4
List of Figures 5


Introduction 6
Gastroparesis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Gastroparesis to Gastrointestinal Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Gastroparesis 22
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Gastroparesis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Gastroparesis 30
Oct 20, 2014: Ironwood Presents IW-9179 Phase IIa Data at American College of Gastroenterology 2014 Annual Scientific Meeting 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
GlaxoSmithKline plc 31
Clinical Trial Overview of GlaxoSmithKline plc 31
Eli Lilly and Company 32
Clinical Trial Overview of Eli Lilly and Company 32
Theravance Biopharma U.S., Inc. 33
Clinical Trial Overview of Theravance Biopharma U.S., Inc. 33
Ocera Therapeutics, Inc. 34
Clinical Trial Overview of Ocera Therapeutics, Inc. 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
Forest Laboratories, Inc. 36
Clinical Trial Overview of Forest Laboratories, Inc. 36
F. Hoffmann-La Roche Ltd. 37
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 37
Evoke Pharma, Inc. 38
Clinical Trial Overview of Evoke Pharma, Inc. 38
Dong-A Socio Group 39
Clinical Trial Overview of Dong-A Socio Group 39
Allegiance Healthcare Corporation 40
Clinical Trial Overview of Allegiance Healthcare Corporation 40
Clinical Trial Overview of Top Institutes / Government 41
The National Institute of Diabetes and Digestive and Kidney Diseases 41
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 41
Mayo Clinic 42
Clinical Trial Overview of Mayo Clinic 42
Johns Hopkins University 43
Clinical Trial Overview of Johns Hopkins University 43
University of Florida 44
Clinical Trial Overview of University of Florida 44
Temple University 45
Clinical Trial Overview of Temple University 45
Royal Adelaide Hospital 46
Clinical Trial Overview of Royal Adelaide Hospital 46
Skane University Hospital 47
Clinical Trial Overview of Skane University Hospital 47
Columbia University 48
Clinical Trial Overview of Columbia University 48
Rouen University Hospital 49
Clinical Trial Overview of Rouen University Hospital 49
University of Iowa 50
Clinical Trial Overview of University of Iowa 50
Five Key Clinical Profiles 51


Appendix 85
Abbreviations 85
Definitions 85
Research Methodology 86
Secondary Research 86
About GlobalData 87
Contact Us 87
Disclaimer 87
Source 88

 

List of Tables

 

Gastroparesis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Gastroparesis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Gastroparesis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Gastroparesis Therapeutics, Global, Clinical Trials by Phase, 2015* 18
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 19
Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Gastroparesis Therapeutics, Global, Suspended Clinical Trials, 2015* 22
Gastroparesis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 23
Gastroparesis Therapeutics, Global, Terminated Clinical Trials, 2015* 24
Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26
Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 31
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 32
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance Biopharma U.S., Inc., 2015* 33
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocera Therapeutics, Inc., 2015* 34
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 35
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2015* 36
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 37
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Evoke Pharma, Inc., 2015* 38
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Socio Group, 2015* 39
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allegiance Healthcare Corporation, 2015* 40
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 41
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 42
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2015* 43
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 44
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Temple University, 2015* 45
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Adelaide Hospital, 2015* 46
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Skane University Hospital, 2015* 47
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 48
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rouen University Hospital, 2015* 49
Gastroparesis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Iowa, 2015* 50


 

List of Figures

 

Gastroparesis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Gastroparesis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Gastroparesis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Gastroparesis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Gastroparesis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 14
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Gastroparesis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Gastroparesis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 17
Gastroparesis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 18
Gastroparesis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 19
Gastroparesis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 20
Gastroparesis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 21
Gastroparesis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Gastroparesis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26
Gastroparesis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27
Gastroparesis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Gastroparesis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 86

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing